April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Characterization Of Ceramide Kinase-Like (CERKL) In The Mammalian Retina
Author Affiliations & Notes
  • Tamar Ben-Yosef
    Genetics Dept - Faculty of Med, Technion, Haifa, Israel
  • Mariela J. Nevet
    Genetics Dept - Faculty of Med, Technion, Haifa, Israel
  • Sharon Vekslin
    Genetics Dept - Faculty of Med, Technion, Haifa, Israel
  • Footnotes
    Commercial Relationships  Tamar Ben-Yosef, None; Mariela J. Nevet, None; Sharon Vekslin, None
  • Footnotes
    Support  This research was supported by the Israel Science Foundation (grant number 567/09 to TB).
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1640. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tamar Ben-Yosef, Mariela J. Nevet, Sharon Vekslin; Characterization Of Ceramide Kinase-Like (CERKL) In The Mammalian Retina. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1640.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : CERKL mutations are associated with severe retinal degeneration. CERKL encodes for a novel ceramide kinase (CERK)-like protein. Both CERK and CERKL harbor a kinase domain related to the diacylglycerol kinases, a Pleckstrin Homology domain, and a CERK-specific region, bearing a putative calcium/calmodulin binding motif. Several studies have been conducted to prove a biochemical similarity between CERK and CERKL enzymatic activities. However, so far there has been no evidence that CERKL phosphorylates ceramide or any other lipid substrate in vitro or in vivo. CERKL’s function in the retina is unknown. The purpose of this work is to characterize CERKL’s retinal expression pattern and function.

Methods: : RT-PCR analysis of mouse retina RNA was used to study Cerkl’s expression at various developmental time points, and to identify its various splice-isoforms. A specific anti-CERKL antibody was used to study the localization of the endogenous CERKL protein in the mouse retina. A calcium-overlay assay was used to determine whether CERKL actually binds calcium. To identify CERKL-binding proteins we used the Ras-Recruitment system.

Results: : Cerkl is expressed in the mouse eye as early as embryonic day 14. In the mouse retina CERKL is located in the ganglion cell layer, in amacrine cells of the inner nuclear layer, and in photoreceptors. CERKL is highly expressed in cone photoreceptors, while its expression level in rod photoreceptors is very low. Based on a calcium-overlay assay, CERKL does not appear to bind calcium. Several putative CERKL-binding proteins were identified, including some that are known to take part in the phototransduction cascade.

Conclusions: : Cerkl’s expression in both mature and embryonic mouse retina, in addition to the severe retinal phenotype associated with human CERKL mutations, indicate that this gene plays a crucial role in retinal activity, and that it may be important for retinal development as well. The high expression level of CERKL in cones correlates with the CERKL-associated phenotype in humans, which involves severe cone degeneration. The identified CERKL-binding partners indicate that CERKL may be linked to the phototransduction cascade.

Keywords: retinal degenerations: hereditary • retinal degenerations: cell biology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×